FDA NDC Directory · JSON-LD · Markdown

Daliresp

NDC 0310-0088 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameroflumilast
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryNew Drug Application (innovator) · App NDA022522
Dosage form / routeTABLET · ORAL
Active ingredientsROFLUMILAST (250 ug/1)
Marketing started20150701
Package count2

External sources

Source: openFDA. Public-domain (CC0).